Paraskevas GP - Search Results

1

Expanding the spectrum of C9ORF72-related neurodegenerative disorders in the Greek population.

Kartanou C, Kontogeorgiou Z, Rentzos M, Potagas C, Aristeidou S, Kapaki E, Paraskevas GP, Constantinides VC, Stefanis L, Papageorgiou SG, Houlden H, Panas M, Koutsis G, Karadima G. Kartanou C, et al. Among authors: paraskevas gp. J Neurol Sci. 2022 Nov 15;442:120450. doi: 10.1016/j.jns.2022.120450. Epub 2022 Oct 5. J Neurol Sci. 2022. PMID: 36252286

2

Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease.

Paraskevas GP, Kapaki E, Libitaki G, Zournas C, Segditsa I, Papageorgiou C. Paraskevas GP, et al. Acta Neurol Scand. 1997 Aug;96(2):88-90. doi: 10.1111/j.1600-0404.1997.tb00245.x. Acta Neurol Scand. 1997. PMID: 9272183

3

Increased cerebrospinal fluid tau protein in multiple sclerosis.

Kapaki E, Paraskevas GP, Michalopoulou M, Kilidireas K. Kapaki E, et al. Among authors: paraskevas gp. Eur Neurol. 2000;43(4):228-32. doi: 10.1159/000008181. Eur Neurol. 2000. PMID: 10828654

4

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E. Kapaki E, et al. Among authors: paraskevas gp. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):401-3. doi: 10.1136/jnnp.71.3.401. J Neurol Neurosurg Psychiatry. 2001. PMID: 11511720 Free PMC article.

5

CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population.

Kapaki E, Paraskevas GP, Zalonis I, Zournas C. Kapaki E, et al. Among authors: paraskevas gp. Eur J Neurol. 2003 Mar;10(2):119-28. doi: 10.1046/j.1468-1331.2003.00562.x. Eur J Neurol. 2003. PMID: 12603286

6

Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism.

Paraskevas GP, Kapaki E, Petropoulou O, Anagnostouli M, Vagenas V, Papageorgiou C. Paraskevas GP, et al. J Neurol Sci. 2003 Nov 15;215(1-2):51-5. doi: 10.1016/s0022-510x(03)00184-9. J Neurol Sci. 2003. PMID: 14568128

7

Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors.

Kapaki E, Ilias I, Paraskevas GP, Theotoka I, Christakopoulou I. Kapaki E, et al. Among authors: paraskevas gp. Acta Neurobiol Exp (Wars). 2003;63(4):389-92. doi: 10.55782/ane-2003-1479. Acta Neurobiol Exp (Wars). 2003. PMID: 15053263 Free article.

8

Neuropsychological correlates of Greek alcoholic patients who report memory disturbances.

Liappas I, Theotoka I, Kapaki E, Ilias I, Paraskevas GP, Rabavilas AD. Liappas I, et al. Among authors: paraskevas gp. Psychol Rep. 2005 Feb;96(1):197-203. doi: 10.2466/pr0.96.1.197-203. Psychol Rep. 2005. PMID: 15825926

9

The cognitive effects of cholinesterase inhibitor treatment in every-day practice.

Kapaki E, Paraskevas GP. Kapaki E, et al. Among authors: paraskevas gp. Curr Med Res Opin. 2005 Jun;21(6):871-5. doi: 10.1185/030079905X46359. Curr Med Res Opin. 2005. PMID: 15969887

10

The diagnostic value of tau protein, beta-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages.

Kapaki E, Liappas I, Paraskevas GP, Theotoka I, Rabavilas A. Kapaki E, et al. Among authors: paraskevas gp. Int J Geriatr Psychiatry. 2005 Aug;20(8):722-9. doi: 10.1002/gps.1351. Int J Geriatr Psychiatry. 2005. PMID: 16035118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters